Shalby Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Shalby Limited cash flow conversion efficiency. Based on the latest financial reports, Shalby Limited (SHALBY) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs138.47 Million ≈ $1.50 Million USD) by net assets (Rs10.03 Billion ≈ $108.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shalby Limited (2012–2026)

Cash flow conversion efficiency of Shalby Limited from 2012 to 2026. This chart illustrates how Shalby Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SHALBY stock price and chart for real-time trading data and today's change.

Shalby Limited Cash Flow Conversion Ratio Explained

Shalby Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shalby Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shalby Limited ranked by their cash flow conversion efficiency. Also see SHALBY market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Bera Holding AS
IS:BERA
0.013x
Wintermar Offshore Marine Tbk
JK:WINS
0.069x
Purple Capital Ltd
JSE:PPE
0.014x
Hamat Group Ltd
TA:HAMAT
0.059x
Shieh Yih Machinery Industry Co Ltd
TWO:4533
0.133x
LBS Bina Group Bhd
KLSE:5789
0.025x
Bank Agris Tbk
JK:AGRS
0.027x
India Pesticides Limited
NSE:IPL
0.084x

Annual Cash Flow Conversion Efficiency for Shalby Limited (2012–2026)

The table below shows the annual cash flow conversion efficiency of Shalby Limited from 2012 to 2026. Review Shalby Limited free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs10.06 Billion
≈ $108.76 Million
Rs-333.59 Million
≈ $-3.61 Million
-0.033x -5.48%
2025-03-31 Rs9.95 Billion
≈ $107.64 Million
Rs-313.01 Million
≈ $-3.39 Million
-0.031x -261.73%
2024-03-31 Rs10.08 Billion
≈ $108.99 Million
Rs195.96 Million
≈ $2.12 Million
0.019x -73.39%
2023-03-31 Rs9.28 Billion
≈ $100.32 Million
Rs677.73 Million
≈ $7.33 Million
0.073x +238.40%
2022-03-31 Rs8.76 Billion
≈ $94.76 Million
Rs189.17 Million
≈ $2.05 Million
0.022x -78.64%
2021-03-31 Rs8.35 Billion
≈ $90.27 Million
Rs843.49 Million
≈ $9.12 Million
0.101x +45.86%
2020-03-31 Rs7.99 Billion
≈ $86.43 Million
Rs553.74 Million
≈ $5.99 Million
0.069x +57.31%
2019-03-31 Rs7.80 Billion
≈ $84.34 Million
Rs343.47 Million
≈ $3.71 Million
0.044x +140.70%
2018-03-31 Rs7.62 Billion
≈ $82.35 Million
Rs139.34 Million
≈ $1.51 Million
0.018x -92.71%
2017-03-31 Rs2.75 Billion
≈ $29.79 Million
Rs691.74 Million
≈ $7.48 Million
0.251x +1118.55%
2016-03-31 Rs2.22 Billion
≈ $23.97 Million
Rs45.68 Million
≈ $494.01K
0.021x -97.14%
2015-03-31 Rs1.71 Billion
≈ $18.47 Million
Rs1.23 Billion
≈ $13.33 Million
0.722x +1936.93%
2014-03-31 Rs1.43 Billion
≈ $15.51 Million
Rs50.81 Million
≈ $549.49K
0.035x -96.07%
2013-03-31 Rs1.06 Billion
≈ $11.43 Million
Rs953.70 Million
≈ $10.31 Million
0.902x +2100.17%
2012-03-31 Rs892.99 Million
≈ $9.66 Million
Rs-40.27 Million
≈ $-435.50K
-0.045x --

About Shalby Limited

NSE:SHALBY India Medical Care Facilities
Market Cap
$140.28 Million
Rs12.97 Billion INR
Market Cap Rank
#17715 Global
#930 in India
Share Price
Rs120.64
Change (1 day)
-1.08%
52-Week Range
Rs113.39 - Rs244.12
All Time High
Rs321.68
About

Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, Paediatric orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardio… Read more